Device manufacturer, as written on reports
Medtronic Cryocath: medical device reports filed with FDA
9,668 reports name it as the manufacturer of the device involved, 2011–2026.
- 9,668
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 1,393
- reports, 12 months to August 2026
- 1,109 in the 12 months before
- 49.3%
- classified as malfunction
- 62.3% across all reports
- 2.6%
- classified as death, as reported
- 0.9% across all reports
9,668 medical device reports received by FDA give Medtronic Cryocath as the manufacturer of the device involved, 0% of the MAUDE database, from February 2011 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
1,393 reports arrived in the 12 months to August 2026, up 26% from 1,109 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (49.3%), injury (48.1%) and death (2.6%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| FlexCath Advance Steerable Sheath | Catheter, steerable | 2,930 | 58 | 3.5% |
| PulseSelect | Percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation | 2,124 | 1,266 | 0.8% |
| Arctic Front Advance Cardiac Cryoablation Catheter | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | 2,045 | 46 | 2.6% |
| Arctic Front Advance Pro Cardiac Cryoablation Catheter | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | 1,206 | 152 | 2.5% |
| Flexcath Steerable Sheath | Catheter, steerable | 365 | 0 | 0.3% |
| CryoConsole | Cardiac ablation percutaneous catheter | 228 | 15 | 1.6% |
| Achieve Mapping Catheter | Catheter, electrode recording, or probe, electrode recording | 167 | 0 | 4.7% |
| Achieve Mapping Catheter - 20 mm | Catheter, electrode recording, or probe, electrode recording | 25 | 82 | 3.1% |
| FlexCath Contour Steerable Sheath | Catheter, steerable | 21 | 399 | 1.5% |
| Achieve Advance Mapping Catheter | Catheter, electrode recording, or probe, electrode recording | 11 | 34 | 4.4% |
| Medtronic | Implantable cardioverter defibrillator (non-crt) | 5 | 17 | 4.4% |
| Attain Ability MRI SureScan | Drug eluting permanent left ventricular (lv) pacemaker electrode | 1 | 162 | 0.3% |
| Attain Command | Catheter, percutaneous | 1 | 12 | 4.4% |
| Deflect | Catheter, percutaneous | 1 | 247 | 0.1% |
| Medtronic Navigation | Neurological stereotaxic instrument | 1 | 69 | 6.7% |
| Micra | Leadless pacemaker | 1 | 524 | 8.4% |
| O-Arm 1000 Imaging System | Image-intensified fluoroscopic x-ray system, mobile | 1 | 2 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| OAE | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | 3,515 | 36.4% |
| DRA | Catheter, steerable | 3,331 | 34.5% |
| QZI | Percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation | 2,125 | 22% |
| LPB | Cardiac ablation percutaneous catheter | 401 | 4.1% |
| DRF | Catheter, electrode recording, or probe, electrode recording | 234 | 2.4% |
| DYB | Introducer, catheter | 20 | 0.2% |
| DQX | Wire, guide, catheter | 9 | 0.1% |
| GEH | Unit, cryosurgical, accessories | 3 | 0% |
| DQY | Catheter, percutaneous | 2 | 0% |
| DRE | Dilator, vessel, for percutaneous catheterization | 2 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Medtronic Cryocath reports
How many FDA device reports name Medtronic Cryocath as manufacturer?
9,668 reports through August 2026, 1,393 of them in the latest 12 months.
Which of its brands appear most often?
FlexCath Advance Steerable Sheath (2,930), PulseSelect (2,124), Arctic Front Advance Cardiac Cryoablation Catheter (2,045), Arctic Front Advance Pro Cardiac Cryoablation Catheter (1,206) and Flexcath Steerable Sheath (365).
Which device types does it report on?
catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (36.4%), catheter, steerable (34.5%), percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation (22%) and cardiac ablation percutaneous catheter (4.1%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.